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ABSTRACT
Objectives Recent public reporting initiatives in 
England highlight general practice variation in indicators 
of diagnostic activity related to cancer. We aimed to 
quantify the size and sources of variation and the 
reliability of practice-level estimates of such indicators, 
to better inform how this information is interpreted and 
used for quality improvement purposes.
Design Ecological cross-sectional study.
Setting English primary care.
Participants All general practices in England with at 
least 1000 patients.
Main outcome measures Sixteen diagnostic activity 
indicators from the Cancer Services Public Health Profiles.
Results Mixed-effects logistic and Poisson regression 
showed that substantial proportions of the observed 
variance in practice scores reflected chance, variably so 
for different indicators (between 7% and 85%). However, 
after accounting for the role of chance, there remained 
substantial variation between practices (typically up to 
twofold variation between the 75th and 25th centiles 
of practice scores, and up to fourfold variation between 
the 90th and 10th centiles). The age and sex profile of 
practice populations explained some of this variation, 
by different amounts across indicators. Generally, the 
reliability of diagnostic process indicators relating to 
broader populations of patients most of whom do not 
have cancer (eg, rate of endoscopic investigations, or 
urgent referrals for suspected cancer (also known as 
‘two week wait referrals’)) was high (≥0.80) or very 
high (≥0.90). In contrast, the reliability of diagnostic 
outcome indicators relating to incident cancer cases (eg, 
per cent of all cancer cases detected after an emergency 
presentation) ranged from 0.24 to 0.54, which is well 
below recommended thresholds (≥0.70).
Conclusions Use of indicators of diagnostic activity in 
individual general practices should principally focus on 
process indicators which have adequate or high reliability 
and not outcome indicators which are unreliable at 
practice level.
InTRoduCTIon
International variations in cancer survival 
have been attributed to healthcare system 
differences in primary care infrastruc-
ture.1 According to this hypothesis, in 
systems with a prominent primary care 
sector, ‘gate-keeping’ by general prac-
titioners results in underutilisation of 
specialist investigations or referrals, 
leading to longer diagnostic intervals and 
poorer clinical outcomes for patients with 
cancer.2 Consequently, increasing atten-
tion is being paid to the role of primary 
care in diagnostic evaluation.3
In England, these considerations 
have led to the development of publicly 
reported diagnostic activity indicators 
for general practices (forming part of the 
Cancer Services Public Health Profile).4 
Broadly, these include two principal fami-
lies of indicators: some relating to broader 
populations of patients most of whom do 
not have cancer, for example, practice 
rates of urgent referrals for suspected 
cancer (hereafter referred to as ‘two week 
wait’ referrals) or endoscopy tests. Some 
other indicators relate only to incident 
cancer cases, for example, the propor-
tion of all cancer diagnoses in a practice 
that were detected following 2-week wait 
referrals, otherwise known as ‘detection 
rate.’ For either class of measures we use 
the term activity (rather than ‘perfor-
mance’) indicators, given lack of evidence 
on levels that represent best practice.
Information from the Cancer Services 
Public Health Profile is used to promote 
reflective practice, particularly following 
evidence suggestive of associations 
between the level of use of 2-week refer-
rals and practice-level cancer survival.5 6 
However, there are also concerns 
about the optimal use of practice-level 
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information on these indicators, given uncertainties 
about their statistical properties and the typically small 
number of new cancer cases annually in an average 
practice.7 Where small numbers are involved there 
may be a considerable role of chance, leading to an 
artefactual inflation of the apparent variation such 
that, in some cases, most of the observed difference 
in practice activity may simply reflect chance (box 1).8
Against the above background, we characterised the 
size and sources of variation for diagnostic activity 
indicators included in the Cancer Services Public 
Health Profile, and the statistical reliability of poten-
tial comparisons of different practices using these 
measures.
MeThodS
In summary, we analysed Cancer Services Public 
Health Profile data together with information on the 
age-sex composition of general practice populations 
to characterise and explain aspects of practice-level 
variation in diagnostic activity. After describing the 
observed variation for each diagnostic activity indi-
cator, we used appropriate mixed-effects regression 
models to estimate the size of the underlying varia-
tion between practices. This underlying variation is 
that which would be seen if the effects of chance were 
not present. It can be thought of as the variation that 
would be seen if each practice had a very large sample 
size (see box 1). These models take into account the 
role of chance and additionally were used to account 
for differences in the make-up of practice populations. 
We further calculated the Spearman-Brown (interunit) 
reliability of each measure, to assess whether each 
diagnostic activity indicator included in the ‘Profile’ 
could reliably distinguish (by which we mean reliably 
rank or classify) general practices on the basis of their 
level of diagnostic activity.1
Data
We focused on Cancer Services Public Health Profile 
for 2013, the most recent year with available data 
at the time of the analysis. In general, practice indi-
cators (table 1, see online supplementary appendix 
1) comprise a ‘numerator’ (eg, the annual number of 
incident cancer cases, referrals or investigations in a 
practice), divided by an appropriate denominator (eg, 
the size of the patient population registered with the 
practice). Practices with <1000 registered patients are 
excluded from the public reporting scheme (which 
resultantly includes information for about 97% of all 
English general practices), and consequently our anal-
yses.
We a priori categorised diagnostic activity indicators 
in those relating to broader populations of patients 
most of whom will not have cancer (diagnostic process 
indicators)—for example, endoscopy-investigated 
patients; and those relating to incident cases of cancer 
(diagnostic outcome indicators)—for example, the 
proportion of patients with cancer diagnosed after an 
emergency presentation—see also Background.
Analysis
After exclusions missing data were rare (see 
online supplementary appendix 3) and a complete case 
analysis was performed. For each indicator, the anal-
ysis comprised four steps.
Estimating the observed variation
To summarise the observed variation between general 
practices (ie, that seen in the publicly reported indi-
cator data), we calculated the variance of the observed 
practice activity. In order to facilitate a mean-
ingful comparison with modelled variance estimates 
described below, this variance was calculated on the 
log odds scale for proportion indicators and the log 
rate scale for rate indicators.
Estimating modelled (underlying) variation
To examine the degree to which observed variation 
reflects chance, we used a regression model including 
a random effect for general practice. These models 
estimate the underlying variance of practice activity 
(rather than that inflated by chance variation—where 
the additional chance variation would be described by 
the binomial or Poisson distributions). Mixed-effects 
logistic regression was used for ‘proportion’ indicators 
(eg, screening coverage) and mixed-effects Poisson 
regression for ‘rate’ indicators (eg, the rate of colonos-
copy investigations, table 1). These models contained 
only a constant term and a random intercept for prac-
tice. Importantly, by using these models we are able 
to handle relatively sparse data (eg, from a single year 
of data collection) to partition the observed variation 
Box 1 Inflation of observed variance by chance.
Where indicators are based on finite numbers, chance 
will inflate the apparent variation between units of 
observation. When indicators represent proportions, 
chance variation will be represented by the binomial 
distribution, whereas for rate indicators chance variation 
will be represented by the Poisson distribution. Just as we 
would not expect practices flipping 10 coins to all record 
precisely five heads (some will record more and some less 
by chance), we would not expect every practice with an 
underlying level of 50% to record exactly that. The effect 
of chance is larger when the numbers involved are small 
and it is this phenomenon which is often displayed in 
funnel plots where the ‘funnel’ is wider at the left of the 
graph where sample sizes are smaller. Where sample sizes 
are large, such that the role of chance is small and thus 
the statistical uncertainty on scores is small, the observed 
variation will closely approximate the underlying 
variation.
group.bmj.com on November 23, 2017 - Published by http://qualitysafety.bmj.com/Downloaded from 
3Abel G, et al. BMJ Qual Saf 2017;0:1–10. doi:10.1136/bmjqs-2017-006607
Original research
into that attributable to chance and that which is 
underlying variation. These are estimates that are 
similar to those that would be obtained from observed 
scores aggregated over many years in a steady state. 
Practice activity was assumed to be normally distrib-
uted on the log odds scale for proportion indicators 
or log rate scale for rate indicators. Using the outputs 
of these models, we compared the variance of the 
modelled (underlying) practice diagnostic activity with 
that of observed practice scores (as above), to estimate 
the percentage of the observed variance (in the log 
odds or log rate scale, as applicable) that is attributable 
to chance.
Estimating modelled variation adjusted for the age-sex profile of 
practice populations
To examine how much of the observed variation 
reflects the age and sex make-up of practice popula-
tions we repeated the regression models additionally 
including variables representing proportions of prac-
tice populations in different age-sex strata (as we 
had 18 age groups, 35 such variables were used after 
excluding one age group-sex stratum which can be 
determined once all others are known and thus adds 
no information). From these ‘adjusted-modelled’ anal-
yses, we estimated the variance of practice activity 
on the log odds or log rate scale as before, adjusted 
for the age and sex make-up of practice populations. 
This variance was compared with the variances for 
the observed and modelled activity to allow respective 
estimations of the proportion of the observed variance 
that is due to chance and practice population demog-
raphy, and the proportion of the modelled variance 
that is due to practice population demography alone.
Distribution of practice activity 
The variances estimated in all above three steps are 
hard to interpret in respect of the reported indicator 
values. For this reason, we plotted the distribution of 
indicator activity in the natural scale. Further, we esti-
mated rate ratio or OR values (as applicable for rate 
and proportion indicators, respectively) comparing the 
75th with the 25th, and the 90th with the 10th centiles 
of the distributions of practice activity for the observed, 
modelled and adjusted-modelled distributions. With 
the observed distribution we used observed centiles 
of the distribution to calculate these ratios, whereas 
for the modelled distributions and adjusted-modelled 
distributions a fully parametric estimation was made 
using the estimated variance of the random effect and 
respective percentiles of the normal distribution.
Estimating reliability
Finally, we used the same models as for estimating 
the underlying variation without adjustment for prac-
tice age-sex profile to estimate the Spearman-Brown 
(interunit) reliability of the reported practice activity. 
Briefly, reliability is a way to assess whether the 
measured activity for a particular organisation can be 
meaningfully distinguished from other organisations 
Table 1 Publicly reported diagnostic process or outcome cancer profile indicators during the study years (see also online supplementary 
appendices 1 and 3)
Indicator name Description (proportion or rate)
Process indicators
  Breast screening coverage Per cent of the eligible practice population (women aged 50–69) screened in the last 36 months
  Cervical screening coverage Per cent of the eligible practice population (women aged 25–64) screened in the target period
  Bowel screening coverage Per cent of the eligible practice population (men and women aged 60–69) screened in the last 36 months
  Sigmoidoscopy rate* Rate per 100 000 registered patients per year
  Colonoscopy rate* Rate per 100 000 registered patients per year
  Upper gastrointestinal endoscopy 
rate*
Rate per 100 000 registered patients per year
  TWW referral rate† Rate per 100 000 registered patients per year
  TWW referral rate (colorectal) Rate per 100 000 registered patients per year
  TWW referral rate (lung) Rate per 100 000 registered patients per year
  TWW referral rate (skin) Rate per 100 000 registered patients per year
  TWW referral rate (breast) Rate per 100 000 registered patients per year
Outcome indicators
  TWW conversion rate Per cent of TWW referrals resulting in a diagnosis of cancer
  TWW detection rate Per cent of new cancer cases treated which resulted from a TWW referral
  Emergency route to diagnosi Per cent of new cancer cases diagnosed via an emergency hospital admission
  Referred route to diagnosi Per cent of new cancer cases diagnosed following outpatient referral to hospital
  Other route to diagnosis Per cent of new cancer cases diagnosed through another route (eg, via screening)
*For these three (endoscopy) indicators some practices had suppressed data (if count <6), and for those we were able to use numerators imputed with 
the average among supressed practices.
†The publicly reported data also include an indirectly age-sex standardised rate not used here.
TWW, two-week wait.
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(ie, whether high and low activity practices for a given 
indicator can be reliably distinguished from each 
other).9 Reliability is a term often used in USA and 
UK literature, but the same construct has also been 
denoted as ‘rankability’ in literature from continental 
Europe. Further details are included in box 2. A reli-
ability coefficient (taking values from 0—lowest reli-
ability to 1—perfect reliability) is estimated for each 
practice specific to its denominator and observed 
activity (see online supplementary appendix 2 for 
details). The median and IQR of practice reliability 
is then found along with the number of years of data 
required for 50% and 90% of practices to reach reli-
ability thresholds of 0.7 and 0.9. These thresholds are 
used following the examples of others,9–11 and while 
we recognise that any cut-off applied to such statistics 
is somewhat arbitrary, it has been suggested that the 
lower threshold (0.7) is desirable for any indicator of 
quality and the higher threshold (0.9) is preferable for 
higher stake applications such as pay for performance. 
12 10
All analyses were performed in Stata V.13.1.
ReSulTS
Between 7687 and 7954 practices were included in the 
analysis (table 2, see online supplementary appendix 
3). The mean list size of these practices was 7034 
(SD 4293) ranging from 1012 to 46 126. The median 
annual number of new cancer cases per practice was 28 
(IQR 15–48). Diagnostic process indicators (relating 
to tested or referred patients) and diagnostic outcome 
indicators (relating to patients with incident cancer) 
had notably different number of cases or events per 
practice. For example, the median annual number 
of persons screened for colorectal cancer (relating 
to the ‘bowel screening coverage’ diagnostic process 
indicator) was 349 per practice; while the median 
annual number of cancer cases detected after 2-week 
wait referrals (relating to ‘detection rate’ diagnostic 
outcome indicator) was 12 per practice (table 2).
Between-practice variation and the role of chance and that of 
practice population demography
Overall the size of modelled (underlying) practice 
variation was substantial, with typically up to twofold 
variation between practices at the 75th and the 25th 
centiles of the distribution, and up to fourfold vari-
ation between practices at the 90th and 10th centiles 
(table 3, columns 7 and 10).
The proportion of overall variance in the observed 
activity that is due to chance ranged from 7% to 45% 
for diagnostic process indicators and from 65% to 85% 
for diagnostic outcome indicators (table 3, column 3). 
After accounting for variation due to chance, vari-
ation attributable to the age-sex profile of practice 
population ranged from 20% to 75% for diagnostic 
process indicators and from 5% to 31% for diagnostic 
outcome indicators (table 3, column 4). The combined 
proportion of variation due to both chance and prac-
tice age-sex profile ranged from 48% to 79% for diag-
nostic process and from 76% to 88% for diagnostic 
outcome indicators (table 3, column 5).
Visualising variation
In figures 1 and 2, we illustrate differences between 
the observed, modelled and adjusted-modelled vari-
ations for a diagnostic process indicator (the rate of 
2-week wait referrals) and an outcome indicator (the 
Box 2 Spearman-Brown (or interunit) reliability.
Spearman-Brown, or interunit, reliability (also known as 
rankability9–11 15 24) is a measure of how reliably units (in 
this case general practices) can be distinguished (ranked, 
classified) from each other for a particular indicator. A 
value of 0 implies that all observed variability is due to 
chance and so units cannot be distinguished at all from 
each other on the basis of such an indicator. In contrast 
a value of 1 implies that all of the observed variability is 
real and thus all practices can be accurately classified. 
Reliability is defined as follows:
 
Reliability = underlying between unit variance
underlying between unit variance + within unit variancen
 
where n is the number of observations for a given 
practice. Often reliability is thought of as the proportion 
of observed variance that is attributable to the underlying 
variance (alternatively, the proportion of overall variance 
not due to chance). However, in ascribing a single 
reliability value to all units we might suggest all have the 
same level of distinguishability. Reliability of binary and 
rate indicators depends on three factors:
 ► unit sample size, with a higher sample size leading to 
more precise unit score estimates and thus increasing 
reliability;
 ► unit score, with percentage scores closer to 50% 
leading to smaller within-unit variances on the 
log odds scale for the same sample size, thus leading 
to more precise unit score estimates and thus 
increasing reliability;
 ► between-unit variance, with larger between-unit 
variances making it easier to distinguish units with 
the same absolute precision of estimated score, thus 
increasing reliability.
Given variation in score and sample size between units 
we follow the example of Adams et al and consider 
reliability to be unit specific rather than a single value 
applying to the whole population.11 For this reason, the 
median reliability values shown in table 2 do not relate 
directly to the proportion of variance of observed activity 
attributable to chance in table 3. The latter are heavily 
influenced by smaller practices with much larger variance 
due to chance.
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proportion of all new cancer diagnoses in a practice 
diagnosed through an emergency presentation).
For 2-week wait referrals (figure 1), the spread of 
observed distribution (illustrated by the histogram) is 
similar to that of the modelled distribution accounting 
for chance (denoted by a blue line), although the 
latter is slightly narrower. This reflects the difference 
between observed and modelled variances for this 
indicator, which is 20%, one of the smallest among all 
indicators (table 3, column 3).
Conversely, for the proportion of patients with 
cancer diagnosed as emergencies (figure 2), the spread 
of the observed variation is far wider than that of 
the modelled variation, indicating that the observed 
differences are grossly inflated by chance. This also 
reflects that a very large proportion (ie, 83%) of the 
observed variation for this indicator is due to chance 
(table 3, column 3). It is worth noting that the peaks in 
the observed distribution at 0 and 0.5 are dominated 
by practices with very few emergency presentations 
(<5).
In both figure 1 and figure 2 the distributions shown 
by red lines (ie, accounting for both chance and the 
age-sex profile of practice population) are somewhat 
narrower than the distributions shown by blue lines 
(which simply account for chance). These differences 
reflect the 40% and 30% of variance beyond chance 
explained by the age-sex profile of practice in these 
two indicators, respectively (table 3, column 4).
Indicator reliability
The reliability of the publicly reported indicators 
included in the ‘Cancer Services Public Health Profile’ 
was bimodal: diagnostic outcome indicators relating 
to incident cancer cases (eg, rate of 2-week wait refer-
rals, or the per cent of cancer cases presenting as emer-
gencies) have low reliability, well below thresholds 
required for high-stake applications and performance 
management (≥0.90) and, indeed, lower than thresh-
olds of merely adequate reliability (≥0.70). These 
include conversion (proportion of all 2-week wait 
referrals resulting in a cancer diagnosis) and detection 
rates (proportion of all new cancers treated which 
resulted from a 2-week wait referral), with median reli-
abilities of 0.54 and 0.32, respectively (table 2). They 
also include the proportions of patients diagnosed via 
various routes (emergency, elective and ‘other’) which 
have median reliabilities of ≤0.33. Reliable estimates 
could be achieved by using multiple years of data for 
these indicators, but often too many to make this prac-
tical (eg, more than 24 years to achieve a reliability of 
at least 0.7 for 90% of practices for the proportion of 
patients diagnosed via an emergency route, table 2).
This contrasts with diagnostic process indicators 
relating to broader populations (eg, patients investi-
gated by endoscopy). Reliability is particularly high 
for all three screening coverage indicators (r≥0.96); 
all three endoscopy activity indicators (r≥0.86) and 
also for most 2-week wait referral indicators (any type 
r=0.97, colorectal, breast and skin cancer, r>0.80 
for all three) (table 2). The single diagnostic process 
indicator with inadequate reliability is the 2-week wait 
referral indicator for suspected lung cancer (r=0.60) 
which, unusually among process indicators, on average 
relates to only few (5) cases per practice.
dISCuSSIon
Summary of main findings
There is substantial variation between English general 
practices in respect of referral or investigation activity 
of relevance to cancer diagnosis, even after the roles of 
chance and the age-sex profile of practices are taken 
Figure 1 Illustration of the distribution of a diagnostic process indicator 
(2-week wait referral) for general practices. Observed values are denoted 
in grey histogram bars. The distribution of underlying practice activity, 
accounting for chance, is denoted with a blue curve line. The distribution 
of underlying practice activity adjusting for age-sex differences in practice 
populations is denoted by a red curve line. TWW, two-week wait.
Figure 2 Illustration of the distribution of a diagnostic outcome 
indicator (per cent of cancer cases diagnosed following an emergency 
presentation) for general practices. Observed values are denoted in grey 
histogram bars. The distribution of underlying practice activity, accounting 
for chance, is denoted with a blue curve line. The distribution of underlying 
practice activity adjusting for age-sex differences in practice populations is 
denoted by a red curve line.
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into account. However, practices can only be reliably 
classified for their propensity for high or low activity 
in respect of diagnostic process indicators (eg, 2-week 
referrals, endoscopy use or screening programme 
coverage). In contrast, diagnostic outcome indica-
tors relating to incident cancer cases (eg, conversion 
or detection rates, or the proportion of cancers diag-
nosed as emergencies) are not reliable and practices 
should not be ranked in respect of such indicators. 
Reliability is driven by three factors: sample size, score 
and between-practice variance. In general, the poor 
reliability of diagnostic outcome indicators reflects 
the small sample size (see box 2). An exception to 
this general pattern is cancer mortality in a general 
practice population, which is an indicator with small 
numbers but modest reliability. It should be noted 
that mortality due to cancer in a general practice is a 
measure of disease burden and the relatively high reli-
ability reflects larger variability between practices due 
to substantial sociodemographic differences in practice 
populations.
Comparison with the literature
We are not aware of prior studies specifically exam-
ining variation and reliability of a wide range of prac-
tice indicators included in the General Practice Profiles 
for Cancer. Observed variation in a small number 
of these indicators has been described previously, 
although previous studies have not formally exam-
ined the degree of variation due to mere chance.13 14 A 
recent study from Scotland has attributed much of the 
variation in three indicators of referral activity (2-week 
wait referrals, and resultant conversion and detection 
rates) to ‘random case-mix.’7 In that paper, all chance 
variation is ascribed to variability in the case mix of 
presenting patients.7 If case mix was dominating the 
observed variation between practices then this could be 
overcome by adjusting or standardising for case mix. 
However, as shown by our study, chance variation 
would exist even in the absence of variable case mix. 
By examining a wide range of diagnostic evaluation 
measures included in our study (eg, regarding prac-
tice-level endoscopy use and screening programme 
coverage) and by quantifying the reliability of the indi-
cators, we have shown that not all diagnostic activity 
indicators in current use are dominated by chance, and 
reporting could concentrate on those which are reli-
able. More broadly, our study adds to the prior liter-
ature on reliability and variability for organisational 
comparisons. Much of the prior literature relates to 
the context of hospital indicators where sample sizes 
are often larger.15 16 17 18 19 Previous studies described 
variation and/or the reliability of other indicators of 
general practice activity or quality chiefly considering 
patient experience, or prescription or cost patterns, 
but not diagnostic use indicators.9 10 20 21 11 22 As has 
been remarked previously, the reliability of process 
measures is generally substantially higher than that of 
outcome measures, as the former encompass broader 
populations of patients with and without the disease 
or outcome of interest, whereas the latter relate to 
smaller populations of actual cases.23 Of course this is 
a generalisation, and it may be the case that outcome 
indicators are reliable, for example, a Dutch study 
found unintended reoperation after colorectal surgery 
to have an acceptable level of reliability.24
Strengths and limitations
We have used appropriate modelling techniques to 
separately account for the role of chance and the influ-
ence of differences in the age-sex make-up of practice 
populations, within the limits of the ecological data 
used. Our methods adjust for practice demography 
but do not account for the individual characteristics of 
patients who were referred or investigated. Individual 
level adjustment would have been preferable to fully 
adjust for confounding that may occur at patient level, 
but individual level case-mix data are not routinely 
collected as part of some of the respective data sets.25 
By taking practice demography into account we may 
have overadjusted as, for example, patients of the same 
age may experience different diagnostic or referral 
activity in practices with averagely older populations.
Our reliability estimates appropriately relate to 
practice activity as it is publicly reported, which, with 
one exception, do not take into account individual 
case mix or the age-sex profile of practice populations. 
Where indicators are used for purposes of service 
planning or resource allocation, information is needed 
on observed as opposed to adjusted indicators. Where 
practice demography is the dominant source of vari-
ation, the reliability without adjustment for demog-
raphy may simply reflect differences in the make-up 
of practice populations rather than real differences in 
clinical practice. In other words, such indicators may 
reliably distinguish practices with fewer older patients 
from those with more.
We have a priori not taken into account the depri-
vation scores of practice populations—because depri-
vation may be a mediator rather than a confounder of 
practice performance. We were not able to encompass 
practitioner-level variation in use of diagnostic tests or 
referrals—such a study is impossible to perform as data 
on diagnostic activity generated by individual doctors 
are not currently collected routinely (only data aggre-
gated at practice level exist). However, other evidence 
indicates that the size of within-practice variation (ie, 
between the GPs of the same practice) is non-ignor-
able.26
Implications
Our study has several implications for policy and 
research. The fact that there is non-ignorable variation 
between practices (beyond that driven by chance and 
the demographic characteristics of the patient popu-
lations they serve) should motivate further inquiries 
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about reasons likely to be responsible for this vari-
ation. This can take two approaches. First, studies 
that will examine potential correlations of diagnostic 
activity with other measures of practice quality and/or 
practice characteristics. Second, qualitative (including 
ethnographic and significant event audit) studies that 
will examine contextual and compositional (doctor or 
patient-related) factors determining diagnostic activity.
In their present form, ‘Practice profiles’ characterise 
practice scores reliably for some indicators but not 
others. These findings can be considered in respect of 
two possible applications. The first is one where all 
practices were ranked against each other for their posi-
tion in the national distribution. As we have shown, 
for unreliable diagnostic outcome indicators such 
rankings will be dominated by chance and are unlikely 
to reflect underlying diagnostic activity. In contrast, 
reliable process indicators are well suited to such use. 
Second, individual practices can be compared with a 
national mean. Normally, uncertainty in practice esti-
mates is taken into account when such comparisons 
are being made, and only practices where the differ-
ence from the national mean is statistically significant 
are flagged. While this obviates the problem of unre-
liably comparing practices against each other, there is 
still a high risk of type II error for unreliable indica-
tors, meaning that many practices whose underlying 
activity is substantially different to the mean will not 
be identified as such. Several options exist to address 
the latter problem. For example, indicators with inad-
equate median reliability (ie, <0.70) can either be 
excluded from the reporting scheme, or be appropri-
ately ‘flagged’ so that their interpretation and use (by 
healthcare professionals or managers, or members of 
the public) can be appropriately informed. The latter 
convention has been adapted by the public reporting 
of the ‘Practice Profiles’ recently (2015).
Evidence nonetheless indicates that greater use 
by general practices of 2-week wait referrals, and 
greater use of upper gastrointestinal endoscopies are 
associated with better clinical outcomes.5 Examining 
potential associations between clinical outcomes and 
other types of diagnostic activity (other than 2-week 
wait referrals and upper gastrointestinal endoscopy) 
would be useful. Future research should also address 
the optimal levels of diagnostic or referral activity 
from the perspective of optimising population health 
outcomes and resource utilisation.
In conclusion, we identify substantial variation 
in practice level diagnostic processes and outcomes 
relating to cancer (beyond those that could be 
expected by chance or the age-sex profiles of practice 
populations), suggesting meaningful improvements 
are possible. Information on diagnostic outcome 
indicators has low reliability, therefore patients, 
clinicians and managers should avoid judging prac-
tices against these indicators. In contrast, diagnostic 
process indicators are statistically reliable and could 
be used to classify practice activity. The findings 
should motivate further research addressing the 
causes and consequences of variation in indicators of 
diagnostic evaluation in primary care. Although we 
examined practice indicators of diagnostic activity 
relevant to cancer, the findings could be relevant 
to other publicly reported primary care indicators, 
particularly if they relate to small number of cases 
per practice. Addressing the challenge of reliable 
measurement and public reporting of organisational 
or provider activity requires both further empirical 
work and a culture change among patients, practi-
tioners and policymakers.
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